47.73.Z - Retail sale of pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
70.21.Z - Head office activities and management consultancy
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0,3 | 0,1 | -74,7 |
EBITDA | 0,1 | 0,4 | 0,1 | -65,8 |
Short time liabilities | 3 | 3,2 | 3,3 | 1 |
Equity capital | -0,8 | -0,5 | -0,5 | 13,6 |
Operating profit (EBIT) | 0,1 | 0,3 | 0,1 | -70,8 |
Assets | 2,2 | 2,7 | 2,8 | 4 |
Net profit (loss) | 0,1 | 0,3 | 0,1 | -72,9 |
Cash | 0,1 | 0,1 | 0,1 | -21,2 |
Net income from sale | 13,6 | 15,4 | 16,6 | 8 |
Liabilities and provisions for liabilities | 3 | 3,2 | 3,3 | 1 |
Working assets | 2,2 | 2,6 | 2,8 | 5,1 |
Depreciation | 0 | 0 | 0 | 6,3 |
% | % | % | p.p. | |
Profitability of capital | -8,4 | -50,3 | -15,8 | 34,5 |
Equity capital to total assets | -37 | -20,2 | -16,8 | 3,4 |
Gross profit margin | 0,5 | 2,2 | 0,5 | -1,7 |
EBITDA Margin | 0,7 | 2,4 | 0,8 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 81 | 77 | 72 | -5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane